Effector Therapeutics Company

eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).

Headquarters: United States
Founded Date: 2012
Technology: Others
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Industry: Genomic and Epigenominc Instabillity